AbbVie Invests $380 Million to Grow Illinois Manufacturing Business
AbbVie Plans Faster U.S. Facility Construction Due to New Tariff Policies In response to the U.S. government’s 100% tariff on branded drugs imposed last October, AbbVie announced plans to expand its U.S. manufacturing operations. The tariffs only affect companies that had not yet begun construction on domestic facilities, giving AbbVie an incentive to accelerate its […]